Total Payments
$1,009
2022 Payments
$22.62
Companies
17
Transactions
62
Medicare Patients
1,342
Medicare Billing
$388,174
Payment Breakdown by Category
Food & Beverage$993.69 (98.5%)
Education$14.90 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $993.69 | 61 | 98.5% |
| Education | $14.90 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $257.65 | 15 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $193.34 | 13 | $0 (2019) |
| Genentech USA, Inc. | $105.22 | 5 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $87.86 | 6 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $67.32 | 5 | $0 (2019) |
| Allergan Inc. | $61.49 | 4 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $28.52 | 2 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $27.08 | 2 | $0 (2019) |
| Shire North American Group Inc | $26.86 | 1 | $0 (2017) |
| Mallinckrodt LLC | $26.03 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $22.62 | 1 | Boston Scientific Corporation ($22.62) |
| 2021 | $14.66 | 1 | Gilead Sciences, Inc. ($14.66) |
| 2019 | $251.97 | 17 | Allergan Inc. ($61.49) |
| 2018 | $194.77 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($56.66) |
| 2017 | $524.57 | 29 | GlaxoSmithKline, LLC. ($201.57) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/30/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: EXALT_ENDO | ||||||
| 02/17/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.66 | General |
| 10/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/23/2019 | JAZZ PHARMACEUTICALS INC. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PAIN | ||||||
| 09/09/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/14/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Education | In-kind items and services | $14.90 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: RESPIRATORY | ||||||
| 05/20/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Respiratory | ||||||
| 05/06/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/29/2019 | Resmed Corp | AirSense (Device) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Sleep | ||||||
| 04/22/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/08/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Respiratory and Allergy | ||||||
| 03/12/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 01/21/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROLOGY | ||||||
| 01/09/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/12/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/20/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 355 | 589 | $325,637 | $82,617 |
| 2022 | 6 | 360 | 697 | $413,456 | $108,077 |
| 2021 | 4 | 369 | 695 | $417,318 | $109,994 |
| 2020 | 4 | 258 | 537 | $324,255 | $87,485 |
Total Patients
1,342
Total Services
2,518
Medicare Billing
$388,174
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 175 | 346 | $242,746 | $61,283 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 80 | 113 | $29,257 | $7,602 | 26.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 53 | $19,525 | $5,515 | 28.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $16,005 | $3,540 | 22.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 12 | 33 | $10,299 | $3,011 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $7,805 | $1,665 | 21.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 204 | 475 | $340,228 | $89,885 | 26.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 59 | 74 | $27,589 | $6,570 | 23.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 53 | 80 | $20,695 | $4,841 | 23.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 20 | 44 | $13,821 | $4,143 | 30.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 13 | 13 | $6,305 | $1,406 | 22.3% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 11 | 11 | $4,818 | $1,232 | 25.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 226 | 476 | $345,543 | $91,203 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 65 | 88 | $32,909 | $7,989 | 24.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 36 | 74 | $23,920 | $7,242 | 30.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 42 | 57 | $14,946 | $3,560 | 23.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 150 | 365 | $265,727 | $72,246 | 27.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 56 | 94 | $35,172 | $8,715 | 24.8% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 23 | 43 | $14,010 | $4,256 | 30.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 35 | $9,346 | $2,268 | 24.3% |
About Dr. Leon Ting, MD
Dr. Leon Ting, MD is a Pulmonary Disease healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740242791.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leon Ting, MD has received a total of $1,009 in payments from pharmaceutical and medical device companies, with $22.62 received in 2022. These payments were reported across 62 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($993.69).
As a Medicare-enrolled provider, Ting has provided services to 1,342 Medicare beneficiaries, totaling 2,518 services with total Medicare billing of $388,174. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Hackensack, NJ
- Active Since 04/05/2006
- Last Updated 11/27/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1740242791
Products in Payments
- ANORO (Drug) $139.85
- BREO (Drug) $117.80
- Esbriet (Biological) $105.22
- STIOLTO (Drug) $79.38
- AVYCAZ (Drug) $61.49
- SPIRIVA RESPIMAT (Drug) $45.22
- SYMBICORT (Drug) $44.24
- ZERBAXA (Drug) $42.15
- STIOLTO RESPIMAT (Drug) $39.10
- OFEV (Drug) $29.64
- BEVESPI AEROSPHERE (Drug) $28.62
- OPSUMIT MACITENTAN (Drug) $28.52
- GLASSIA (Biological) $26.86
- OFIRMEV (Drug) $26.03
- CUBICIN RF (Drug) $25.17
- XARELTO (Drug) $25.10
- EXALT Model D (Device) $22.62
- AirSense (Device) $18.74
- SAMSCA (Drug) $17.43
- FASENRA (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Hackensack
Dr. Emanuele Santomauro, Md, MD
Pulmonary Disease — Payments: $383,229
Pulmonary Disease $383,229
Dr. Nadeem Ali, M.d, M.D
Pulmonary Disease — Payments: $65,634
Pulmonary Disease $65,634
Dr. David Orr, Do, DO
Pulmonary Disease — Payments: $14,176
Pulmonary Disease $14,176
Dr. John Villa, Do, DO
Pulmonary Disease — Payments: $14,032
Pulmonary Disease $14,032
Dr. Keith Rose, M.d, M.D
Pulmonary Disease — Payments: $12,026
Pulmonary Disease $12,026
Dr. Sean Sadikot, M.d, M.D
Pulmonary Disease — Payments: $6,912
Pulmonary Disease $6,912